Andrea Riccardo Filippi

Full Professor

University of Pavia

Italy

Research Interests

Explore related searches

Professors in Italy Professors in Medical Imaging Medical Imaging professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Andrea Riccardo Filippi is a Full Professor at the University of Pavia, Italy. His research primarily focuses on lung cancer treatment modalities, including the integration of immunotherapy and radiotherapy for advanced and unresectable cases. His recent publications address various aspects of non-small-cell lung cancer management and the evolving landscape of treatment for Hodgkin lymphoma, emphasizing prognostication and innovative therapeutic strategies.

Articles (22)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Collaborators (14)

Michela BUGLIONE DI MONALE E BASTIA

Prof

University of Brescia

ITALY

View details

Paolo Borghetti

Brescia University College

ITALY

View details

Charles Simone

Professor and Chief Medical Officer

UNITED STATES

View details

Daniel C. Christoph

Chief of Division

GERMANY

View details

Andrea Gallamini

National and Kapodistrian University of Athens

FRANCE

View details

Pilar Garrido López

Head Medical Oncology Department

HOSPITAL UNIVERSITARIO RAMÓN Y CAJAL

SPAIN

View details

Lorenzo Preda

University of Pavia

ITALY

View details

Maja Vestmø Maraldo

Copenhagen University Hospital

DENMARK

View details

John Field

Clinical Professor of Molecular Oncology

UNITED KINGDOM

View details

Giulia M. Stella

ITALY

View details

Chandra Bortolotto

ITALY

View details

Anna Santacaterina

Chief of Radiation Oncology

ITALY

View details

Marta Scorsetti

Full Professor in Diagnostic Imaging and Radiotherapy

Humanitas University

ITALY

View details

Claudia Sangalli

Fondazione IRCCS Istituto Nazionale dei Tumori

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Andrea Riccardo Filippi

Research Interests

Explore related searches

Contact this professor

About

Articles (22)

Durvalumab after radiotherapy in patients with unresectable stage III non-small-cell lung cancer ineligible for chemotherapy: the DUART phase II nonrandomized controlled study

Chemotherapy-Free Treatment with Radiotherapy and Immunotherapy for Locally Advanced Non-Small Cell Lung Cancer

Real-world outcomes with durvalumab after chemoradiotherapy in patients with unresectable stage III NSCLC: interim analysis of overall survival from PACIFIC-R

Toward a paradigm shift in prognostication and treatment of early-stage Hodgkin lymphoma.

A Glimpse Into the Future for Unresectable Stage III Non-Small Cell Lung Cancer

CT and MRI radiomic features of lung cancer (NSCLC): comparison and software consistency

Future perspectives of radiation therapy for Hodgkin Lymphoma: Risk-adapted, response-adapted, and safer than before

MDT-BRIDGE: Neoadjuvant Durvalumab Plus Chemotherapy Followed by Either Surgery and Adjuvant Durvalumab or Chemoradiotherapy and Consolidation Durvalumab in Resectable or Borderline-resectable Stage IIB–IIIB NSCLC

Management of patients with extensive small-cell lung cancer in the immunotherapy era: An Italian consensus through a Delphi approach

The Role of Native T1 and T2 Mapping Times in Identifying PD-L1 Expression and the Histological Subtype of NSCLCs

Editorial: Imaging assessment of response to immunotherapy

New options and open issues in the management of unresectable stage III and in early-stage NSCLC: A report from an expert panel of Italian medical and radiation oncologists – INTERACTION group

Performance of an AI algorithm during the different phases of the COVID pandemics: what can we learn from the AI and vice versa.

Correlation between PD-L1 Expression of Non-Small Cell Lung Cancer and Data from IVIM-DWI Acquired during Magnetic Resonance of the Thorax: Preliminary Results.

‘Le Roi est mort, vive le Roi’: New Roles of Radiotherapy in the Treatment of Lymphomas in Combination With Immunotherapy

Almost one year of COVID-19 pandemic: how radiotherapy centers have counteracted its impact on cancer treatment in Lombardy, Italy. CODRAL/AIRO-L study

An integrated approach to cardioprotection in lymphomas

Open issues in the therapeutic management of unresectable stage III NSCLC in the immunotherapy era

Preliminary report on harmonization of features extraction process using the ComBat tool in the multi-center “Blue Sky Radiomics” study on stage III unresectable NSCLC

Unmet needs in the management of unresectable stage III non-small cell lung cancer: a review after the ‘radio talk’ webinars

A Systematic Review on Intensity Modulated Radiation Therapy for Mediastinal Hodgkin’s Lymphoma

DUART: durvalumab after radiotherapy in patients with unresectable, stage III NSCLC who are ineligible for chemotherapy

Collaborators (14)

Michela BUGLIONE DI MONALE E BASTIA

Paolo Borghetti

Charles Simone

Daniel C. Christoph

Andrea Gallamini

Pilar Garrido López

Lorenzo Preda

Maja Vestmø Maraldo

John Field

Giulia M. Stella

Chandra Bortolotto

Anna Santacaterina

Marta Scorsetti

Claudia Sangalli

Make your next move.